These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18618303)

  • 1. A common haplotype within the PON1 promoter region is associated with sporadic ALS.
    Landers JE; Shi L; Cho TJ; Glass JD; Shaw CE; Leigh PN; Diekstra F; Polak M; Rodriguez-Leyva I; Niemann S; Traynor BJ; McKenna-Yasek D; Sapp PC; Al-Chalabi A; Wills AM; Brown RH
    Amyotroph Lateral Scler; 2008 Oct; 9(5):306-14. PubMed ID: 18618303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.
    Cronin S; Greenway MJ; Prehn JH; Hardiman O
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):984-6. PubMed ID: 17702780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase cluster polymorphisms are associated with sporadic ALS.
    Saeed M; Siddique N; Hung WY; Usacheva E; Liu E; Sufit RL; Heller SL; Haines JL; Pericak-Vance M; Siddique T
    Neurology; 2006 Sep; 67(5):771-6. PubMed ID: 16822964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden.
    Valdmanis PN; Kabashi E; Dyck A; Hince P; Lee J; Dion P; D'Amour M; Souchon F; Bouchard JP; Salachas F; Meininger V; Andersen PM; Camu W; Dupré N; Rouleau GA
    Neurology; 2008 Aug; 71(7):514-20. PubMed ID: 18695162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival.
    Verde F; Tiloca C; Morelli C; Doretti A; Poletti B; Maderna L; Messina S; Gentilini D; Fogh I; Ratti A; Silani V; Ticozzi N
    Neurol Sci; 2019 Jul; 40(7):1469-1473. PubMed ID: 30903418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
    Morahan JM; Yu B; Trent RJ; Pamphlett R
    Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.
    Wills AM; Cronin S; Slowik A; Kasperaviciute D; Van Es MA; Morahan JM; Valdmanis PN; Meininger V; Melki J; Shaw CE; Rouleau GA; Fisher EM; Shaw PJ; Morrison KE; Pamphlett R; Van den Berg LH; Figlewicz DA; Andersen PM; Al-Chalabi A; Hardiman O; Purcell S; Landers JE; Brown RH
    Neurology; 2009 Jul; 73(1):16-24. PubMed ID: 19321847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of PON polymorphisms in sporadic ALS in a Chinese population.
    Chen Y; Huang R; Chen K; Song W; Yang Y; Zhao B; Li J; Shang HF
    Neurobiol Aging; 2012 Dec; 33(12):2949.e1-3. PubMed ID: 22884547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of PON polymorphisms with sporadic ALS in an Italian population.
    Ricci C; Battistini S; Cozzi L; Benigni M; Origone P; Verriello L; Lunetta C; Cereda C; Milani P; Greco G; Patrosso MC; Causarano R; Caponnetto C; Giannini F; Corbo M; Penco S
    Neurobiol Aging; 2011 Mar; 32(3):552.e7-13. PubMed ID: 20381198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.
    Landers JE; Melki J; Meininger V; Glass JD; van den Berg LH; van Es MA; Sapp PC; van Vught PW; McKenna-Yasek DM; Blauw HM; Cho TJ; Polak M; Shi L; Wills AM; Broom WJ; Ticozzi N; Silani V; Ozoguz A; Rodriguez-Leyva I; Veldink JH; Ivinson AJ; Saris CG; Hosler BA; Barnes-Nessa A; Couture N; Wokke JH; Kwiatkowski TJ; Ophoff RA; Cronin S; Hardiman O; Diekstra FP; Leigh PN; Shaw CE; Simpson CL; Hansen VK; Powell JF; Corcia P; Salachas F; Heath S; Galan P; Georges F; Horvitz HR; Lathrop M; Purcell S; Al-Chalabi A; Brown RH
    Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9004-9. PubMed ID: 19451621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.
    van Blitterswijk M; Blokhuis A; van Es MA; van Vught PW; Rowicka PA; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 Aug; 33(8):1845.e1-3. PubMed ID: 22330174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase gene polymorphisms and sporadic ALS.
    Slowik A; Tomik B; Wolkow PP; Partyka D; Turaj W; Malecki MT; Pera J; Dziedzic T; Szczudlik A; Figlewicz DA
    Neurology; 2006 Sep; 67(5):766-70. PubMed ID: 16822965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between PON1 and population density in amyotrophic lateral sclerosis.
    Diekstra FP; Beleza-Meireles A; Leigh NP; Shaw CE; Al-Chalabi A
    Neuroreport; 2009 Jan; 20(2):186-90. PubMed ID: 19104460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale pathways-based association study in amyotrophic lateral sclerosis.
    Kasperaviciute D; Weale ME; Shianna KV; Banks GT; Simpson CL; Hansen VK; Turner MR; Shaw CE; Al-Chalabi A; Pall HS; Goodall EF; Morrison KE; Orrell RW; Beck M; Jablonka S; Sendtner M; Brockington A; Ince PG; Hartley J; Nixon H; Shaw PJ; Schiavo G; Wood NW; Goldstein DB; Fisher EM
    Brain; 2007 Sep; 130(Pt 9):2292-301. PubMed ID: 17439985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
    Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.
    Diekstra FP; Saris CG; van Rheenen W; Franke L; Jansen RC; van Es MA; van Vught PW; Blauw HM; Groen EJ; Horvath S; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; Robberecht W; Andersen PM; Melki J; Meininger V; Hardiman O; Landers JE; Brown RH; Shatunov A; Shaw CE; Leigh PN; Al-Chalabi A; Ophoff RA; van den Berg LH; Veldink JH
    PLoS One; 2012; 7(4):e35333. PubMed ID: 22509407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome analysis of sporadic amyotrophic lateral sclerosis.
    Dunckley T; Huentelman MJ; Craig DW; Pearson JV; Szelinger S; Joshipura K; Halperin RF; Stamper C; Jensen KR; Letizia D; Hesterlee SE; Pestronk A; Levine T; Bertorini T; Graves MC; Mozaffar T; Jackson CE; Bosch P; McVey A; Dick A; Barohn R; Lomen-Hoerth C; Rosenfeld J; O'connor DT; Zhang K; Crook R; Ryberg H; Hutton M; Katz J; Simpson EP; Mitsumoto H; Bowser R; Miller RG; Appel SH; Stephan DA
    N Engl J Med; 2007 Aug; 357(8):775-88. PubMed ID: 17671248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase gene mutations in amyotrophic lateral sclerosis.
    Ticozzi N; LeClerc AL; Keagle PJ; Glass JD; Wills AM; van Blitterswijk M; Bosco DA; Rodriguez-Leyva I; Gellera C; Ratti A; Taroni F; McKenna-Yasek D; Sapp PC; Silani V; Furlong CE; Brown RH; Landers JE
    Ann Neurol; 2010 Jul; 68(1):102-7. PubMed ID: 20582942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.